
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 22 years ago
Commentaryover 22 years ago
Post Testover 22 years ago
Faculty Disclosure Statementover 22 years ago
Metabolic syndrome: A new target of therapy?



